AMTI Insider Trading
Notice: This stock is marked as potentially delisted. It may not be actively trading.
Insider Ownership Percentage: 15.90%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00
Applied Molecular Transport Share Price & Price History
Current Price: $0.26
Price Change: +0.30 (1.20%)
As of 12/28/2023 01:00 AM ET
Applied Molecular Transport Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 11/22/2023 | Brandon Hants | CFO | Sell | 61,494 | $0.16 | $9,839.04 | 301,225 |  |
| 11/22/2023 | Shawn Cross | CEO | Sell | 110,802 | $0.16 | $17,728.32 | 545,499 | |
| 11/22/2023 | Tahir Mahmood | Director | Sell | 286,320 | $0.16 | $45,811.20 | 484,738 | |
| 11/15/2023 | Brandon Hants | CFO | Sell | 50,146 | $0.16 | $8,023.36 | 362,719 | |
| 11/15/2023 | Shawn Cross | CEO | Sell | 90,447 | $0.16 | $14,471.52 | 656,301 | |
| 10/6/2023 | Tahir Mahmood | Director | Sell | 184,442 | $0.16 | $29,510.72 | 771,058 | |
| 9/29/2023 | Brandon Hants | CFO | Sell | 107,540 | $0.16 | $17,206.40 | 415,786 | |
| 9/29/2023 | Shawn Cross | CEO | Sell | 193,960 | $0.16 | $31,033.60 | 752,307 | |
| 9/5/2023 | Brandon Hants | CFO | Sell | 718 | $0.21 | $150.78 | 412,865 | |
| 9/5/2023 | Shawn Cross | CEO | Sell | 1,253 | $0.21 | $263.13 | 746,748 | |
| 9/5/2023 | Tahir Mahmood | Director | Sell | 2,245 | $0.21 | $471.45 | 69,389 | |
| 6/2/2023 | Brandon Hants | CFO | Sell | 2,203 | $0.24 | $528.72 | 413,583 | |
| 6/2/2023 | Shawn Cross | CEO | Sell | 4,306 | $0.24 | $1,033.44 | 748,001 | |
| 6/2/2023 | Tahir Mahmood | Director | Sell | 1,992 | $0.24 | $478.08 | 71,634 | |
| 12/2/2022 | Brandon Hants | CFO | Sell | 1,959 | $1.05 | $2,056.95 | 32,819 | |
| 12/2/2022 | Douglas A Rich | Insider | Sell | 4,229 | $1.05 | $4,440.45 | 49,798 | |
| 12/2/2022 | Randall Mrsny | Director | Sell | 418 | $1.05 | $438.90 | 21,136 | |
| 12/2/2022 | Shawn Cross | COO | Sell | 3,893 | $1.05 | $4,087.65 | 61,090 | |
Applied Molecular Transport Institutional Trading History
| Reporting Date | Hedge Fund | Shares Held | Market Value | % of Portfolio | Quarterly Change in Shares | Ownership in Company | Details |
|---|
| 11/15/2023 | Laurion Capital Management LP | 217,828 | $34K | 0.0% | -43.8% | 0.527% |  |
| 5/11/2023 | EPIQ Capital Group LLC | 8,721,447 | $3.60M | 1.8% | -0.5% | 22.249% | |
| 2/15/2023 | Founders Fund VI Management LLC | 826,607 | $0.35M | 3.7% | +153.1% | 2.123% | |
| 2/14/2023 | Susquehanna International Group LLP | 68,540 | $29K | 0.0% | -32.9% | 0.176% | |
| 10/17/2022 | Burleson & Company LLC | 36,212 | $35K | 0.0% | -50.9% | 0.093% | |
| 8/15/2022 | Laurion Capital Management LP | 481,600 | $1.40M | 0.0% | N/A | 1.238% | |
| 8/11/2022 | Trexquant Investment LP | 46,421 | $0.14M | 0.0% | -47.5% | 0.119% | |
| 8/11/2022 | Healthcare of Ontario Pension Plan Trust Fund | 128,000 | $0.37M | 0.0% | -29.3% | 0.329% | |
| 7/7/2022 | AdvisorNet Financial Inc | 15,800 | $46K | 0.0% | +690.0% | 0.041% | |
| 6/30/2022 | Amalgamated Bank | 4,085 | $31K | 0.0% | N/A | 0.011% | |
| 5/12/2022 | Healthcare of Ontario Pension Plan Trust Fund | 181,000 | $1.36M | 0.0% | N/A | 0.468% | |
| 5/11/2022 | GSA Capital Partners LLP | 71,073 | $0.53M | 0.1% | +10.8% | 0.184% | |
| 5/5/2022 | New York State Common Retirement Fund | 17,158 | $0.13M | 0.0% | -15.7% | 0.044% | |
| 4/25/2022 | Burleson & Company LLC | 73,803 | $0.56M | 0.1% | -15.6% | 0.191% | |
| 4/21/2022 | Pacific Heights Asset Management LLC | 320,000 | $2.41M | 0.2% | +10.3% | 0.828% | |
| 2/14/2022 | PDT Partners LLC | 31,248 | $0.44M | 0.0% | +144.7% | 0.081% | |
| 2/14/2022 | Virtus ETF Advisers LLC | 12,313 | $0.17M | 0.1% | +184.2% | 0.032% | |
| 2/14/2022 | GSA Capital Partners LLP | 64,153 | $0.90M | 0.1% | +30.7% | 0.167% | |
| 2/9/2022 | EPIQ Capital Group LLC | 9,075,488 | $126.88M | 22.5% | +0.7% | 23.579% | |
| 2/9/2022 | Alps Advisors Inc. | 44,544 | $0.62M | 0.0% | -5.4% | 0.116% | |
| 2/8/2022 | Northern Trust Corp | 237,878 | $3.33M | 0.0% | -1.4% | 0.618% | |
| 1/25/2022 | Burleson & Company LLC | 87,462 | $1.22M | 0.2% | -23.5% | 0.227% | |
| 11/16/2021 | Squarepoint Ops LLC | 15,350 | $0.40M | 0.0% | N/A | 0.040% | |
| 11/16/2021 | Two Sigma Advisers LP | 101,200 | $2.62M | 0.0% | +892.2% | 0.263% | |
| 11/16/2021 | Two Sigma Investments LP | 137,488 | $3.56M | 0.0% | N/A | 0.358% | |
| 11/16/2021 | Voloridge Investment Management LLC | 29,332 | $0.76M | 0.0% | -38.3% | 0.076% | |
| 11/16/2021 | Millennium Management LLC | 118,164 | $3.06M | 0.0% | N/A | 0.308% | |
| 11/16/2021 | Citadel Advisors LLC | 173,007 | $4.48M | 0.0% | N/A | 0.450% | |
| 11/16/2021 | Capital Research Global Investors | 1,154,180 | $29.86M | 0.0% | -70.6% | 3.004% | |
| 11/16/2021 | Capital World Investors | 4,225,688 | $109.32M | 0.0% | +0.7% | 10.997% | |
| 11/15/2021 | Point72 Hong Kong Ltd | 2,389 | $62K | 0.0% | N/A | 0.006% | |
| 11/15/2021 | Cubist Systematic Strategies LLC | 31,548 | $0.82M | 0.0% | N/A | 0.082% | |
| 11/15/2021 | California State Teachers Retirement System | 22,667 | $0.59M | 0.0% | -33.1% | 0.059% | |
| 11/15/2021 | Marshall Wace LLP | 11,522 | $0.30M | 0.0% | +36.5% | 0.030% | |
| 11/15/2021 | Franklin Resources Inc. | 1,017,515 | $26.32M | 0.0% | +0.1% | 2.648% | |
| 11/15/2021 | GSA Capital Partners LLP | 49,102 | $1.27M | 0.1% | N/A | 0.128% | |
| 11/12/2021 | Trexquant Investment LP | 9,932 | $0.26M | 0.0% | N/A | 0.026% | |
| 11/12/2021 | Renaissance Technologies LLC | 32,500 | $0.84M | 0.0% | N/A | 0.085% | |
| 11/12/2021 | EPIQ Capital Group LLC | 9,009,055 | $233.06M | 24.1% | +2.8% | 23.446% | |
| 11/12/2021 | The Manufacturers Life Insurance Company | 12,991 | $0.34M | 0.0% | -5.7% | 0.034% | |
| 11/12/2021 | Geode Capital Management LLC | 336,490 | $8.70M | 0.0% | -8.4% | 0.876% | |
| 11/10/2021 | Goldman Sachs Group Inc. | 76,532 | $1.98M | 0.0% | +156.0% | 0.199% | |
| 11/10/2021 | Citigroup Inc. | 34,200 | $0.89M | 0.0% | -54.6% | 0.089% | |
| 11/10/2021 | Rafferty Asset Management LLC | 46,664 | $1.21M | 0.0% | -1.6% | 0.121% | |
| 11/10/2021 | Alliancebernstein L.P. | 25,000 | $0.65M | 0.0% | -7.7% | 0.065% | |
| 11/9/2021 | BlackRock Inc. | 1,875,410 | $48.52M | 0.0% | +6.0% | 4.881% | |
| 11/8/2021 | Swiss National Bank | 25,400 | $0.66M | 0.0% | +10.0% | 0.066% | |
| 11/5/2021 | Advisor Group Holdings Inc. | 10,000 | $0.26M | 0.0% | N/A | 0.026% | |
| 11/4/2021 | Deutsche Bank AG | 19,789 | $0.51M | 0.0% | +28.9% | 0.052% | |
| 11/2/2021 | Burleson & Company LLC | 114,277 | $2.96M | 0.4% | +7.5% | 0.297% | |
| 11/2/2021 | New York State Common Retirement Fund | 20,413 | $0.53M | 0.0% | -7.9% | 0.053% | |
| 11/1/2021 | SG Americas Securities LLC | 12,825 | $0.33M | 0.0% | N/A | 0.033% | |
| 9/3/2021 | Parametric Portfolio Associates LLC | 24,140 | $1.10M | 0.0% | +189.3% | 0.063% | |
Data available starting January 2016
Applied Molecular Transport Inc., a clinical-stage biopharmaceutical company, engages in the design and development of a pipeline of oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. The company's lead product candidate is AMT-101, a gastrointestinal (GI) selective oral fusion of rhIL-10 that is in Phase II clinical trials to treat patients with chronic pouchitis, as well as is in Phase II development to treat patients with rheumatoid arthritis. It develops AMT-126, a GI-selective oral fusion of interleukin 22, which is in a Phase I clinical trial for diseases related to intestinal epithelium barrier function defects. The company, through its technology platform, designs and develops various oral and respiratory biologic therapeutic modalities, such as peptides, proteins, antibodies, antibody fragments, and ribonucleic acid therapeutics. Applied Molecular Transport Inc. was founded in 2010 and is headquartered in South San Francisco, California. As of December 27, 2023, Applied Molecular Transport Inc. operates as a subsidiary of Cyclo Therapeutics, Inc.
Read More on Applied Molecular Transport
Volume
N/A
Average Volume
470,969 shs
Market Capitalization
$10.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Beta
2.28
